Literature DB >> 19672896

Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.

Holm H Uhlig1, Fiona Powrie.   

Abstract

Mouse models of intestinal inflammation resemble aspects of inflammatory bowel disease in humans. These models have provided important insights into mechanisms that control intestinal homeostasis and regulation of intestinal inflammation. This viewpoint discusses themes that have emerged from mouse models of intestinal inflammation including bacterial recognition, autophagy, the IL-23/Th-17 axis of inflammation as well as the role of negative regulators. Many of the pathways highlighted by model systems have been identified in recent genome-wide association studies in human validating the relevance of mouse models to human inflammatory bowel disease. Understanding of the complex biological mechanisms that lead to intestinal inflammation in mouse models may help to define targets for treatment of human diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672896     DOI: 10.1002/eji.200939602

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 2.  Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria.

Authors:  Chen Varol; Ehud Zigmond; Steffen Jung
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

3.  Synthetic small intestinal scaffolds for improved studies of intestinal differentiation.

Authors:  Cait M Costello; Jia Hongpeng; Shahab Shaffiey; Jiajie Yu; Nina K Jain; David Hackam; John C March
Journal:  Biotechnol Bioeng       Date:  2014-01-22       Impact factor: 4.530

Review 4.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

Review 5.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Takaaki Tsunematsu; Yasusei Kudo; Naozumi Ishimaru
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 6.  Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells.

Authors:  Arthur Mortha; Andreas Diefenbach
Journal:  Cell Mol Life Sci       Date:  2011-09-09       Impact factor: 9.261

Review 7.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

8.  Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.

Authors:  Mi Na Kim; Seong-Joon Koh; Jung Mogg Kim; Jong Pil Im; Hyun Chae Jung; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Neither direct nor developmental exposure to bisphenol A alters the severity of experimental inflammatory colitis in mice.

Authors:  Anirban Roy; Alison Gaylo; Wenqing Cao; Lawrence J Saubermann; B Paige Lawrence
Journal:  J Immunotoxicol       Date:  2013-01-03       Impact factor: 3.000

10.  Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases.

Authors:  William A Rose; Kaori Sakamoto; Cynthia A Leifer
Journal:  BMC Immunol       Date:  2012-08-01       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.